Sign in

CIK 0001727196

  • Non-accelerated filer

Scholar Rock Holding Corp

Sign in to watch
Ticker
SRRK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
823750435
Phone
+1 857-259-3860
Business address
301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
Open-market buys, last 90 days
$11,999,922
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. AKKARAJU SRINIVAS +$12.0M Director 1 filing

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-04-28 Invus Public Equities, L.P. 10% owner Purchase +31,557 $6.43 $203K 9,059,507
2023-04-06 Brudnick Richard Director Grant or award · Stock Option (Right to Buy) +56,000 56,000
2023-02-13 Myles Edward H COO & CFO Grant or award +63,750 210,929
2023-02-13 Myles Edward H COO & CFO Grant or award · Stock Option (Right to Buy) +85,000 85,000
2023-02-13 Parlavecchio Caryn CHRO Grant or award +46,875 122,590
2023-02-13 Parlavecchio Caryn CHRO Grant or award · Stock Option (Right to Buy) +62,500 62,500
2023-02-13 Backstrom Jay T. CHIEF EXECUTIVE OFFICER Grant or award +150,000 150,000
2023-02-13 Backstrom Jay T. CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (Right to Buy) +200,000 200,000
2023-02-13 Ho Junlin GENERAL COUNSEL Grant or award +46,875 162,937
2023-02-13 Ho Junlin GENERAL COUNSEL Grant or award · Stock Option (Right to Buy) +62,500 62,500
2023-01-17 Myles Edward H COO & CFO Shares withheld for taxes −7,043 $11.29 $80K 147,179
2023-01-17 Parlavecchio Caryn CHRO Shares withheld for taxes −2,934 $11.28 $33K 75,715
2023-01-17 Ho Junlin GENERAL COUNSEL Shares withheld for taxes −4,529 $11.29 $51K 116,062
2023-01-09 Invus Public Equities, L.P. 10% owner Sale −1,094 $9.48 $10K 9,027,950
2023-01-05 Invus Public Equities, L.P. 10% owner Purchase +48,774 $9.33 $455K 9,029,044
2022-11-14 Marantz Jing L. Chief Medical Officer Grant or award · Stock Option (right to buy) +250,000 250,000
2022-10-25 Invus Public Equities, L.P. 10% owner Purchase +130,265 $8.04 $1.0M 8,980,270
2022-10-04 Invus Public Equities, L.P. 10% owner Purchase +66,000 $7.89 $521K 8,850,005
2022-10-03 Invus Public Equities, L.P. 10% owner Purchase +33,971 $7.03 $239K 8,784,005
2022-09-20 Backstrom Jay T. CEO-Elect Grant or award · Stock Option (right to buy) +1,000,000 1,000,000

Page 20 of 22 · 422 trades